Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast add-on to salmeterol to assess prevention of beta-agonist tolerance in mild adult asthma
2005-003991-39Phase 4Completed
- Sponsor
- Institut für Atemwegsforschung
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of montelukast and salmeterol in asthma (2 arms), sponsored by Institut für Atemwegsforschung. Primary endpoints: Post-salmeterol PC20 methacholine on day 14 and Degree of tolerance from day 1 to day 14. Started May 2006; status: completed.
02
Drugs
montelukastsalmeterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2005-003991-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003991-39.